Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance

Abstract

B7-H1, a recently described member of the B7 family of costimulatory molecules, is thought to be involved in tumor immune escape by inducing T-cell apoptosis. In order to investigate the relationship between B7-H1 and immune escape of bladder cancer, B7-H1 expression in 50 cases of bladder cancer was detected by using immunohistochemical method. Survival curves were constructed using the Kaplan-Meier method and independent prognostic factors were evaluated using the Cox regression model. Our results showed that the positive rate of B7-H1 immunostaining in normal bladder tissue and bladder cancer was 0 and 72% respectively. The expression of B7-H1 was strongly associated with the pathological grade, clinical stage and recurrence (P<0.05). The survival rate was significantly lower in patients with B7-H1 positive group than in those with B7-H1 negative group and multi-variable analysis revealed that B7-H1 could be regarded as an independent factor in evaluating the prognosis of bladder cancer. It is concluded that the expression of B7-H1 is strongly associated with neoplastic progression and prognosis of bladder cancer. The manipulation of B7-H1 may become a beneficial target for immunotherapy in human bladder cancer.

Keywords

bladder neoplasm / costimulatory molecule / B7-H1 / immune escape

References

[1] IgneyF.H., KrammerP.H.. Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol, 2002, 71(6): 907-920

[2] PardollD., AllisonJ.. Cancer immunotherapy: Breaking the barriers to harvest the crop. Nat Med, 2004, 10(9): 887-892

[3] LymanM.A., AungS., BiggsJ.A., et al. . A spontaneously arising pancreatic tumor does not promote the differentiation of naive CD8⁺ T lymphocytes into effector CTL. J Immunol, 2004, 172(11): 6558-6567

[4] DongH., StromeS.E., SalomaoD.R., et al. . Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med, 2002, 8(8): 793-800

[5] JunkoH., MingcongW., MegumiM., et al. . B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts. J Immunol, 2006, 177(21): 5928-5935

[6] FumihikoT., KaeT., NorikoO., et al. . Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma. Oral Oncol, 2006, 42(3): 268-274

[7] WintterleS., SchreinerB., MitsdoerfferM., et al. . Expression of the B7-Related Molecule B7-H1 by Glioma Cells: A Potential Mechanism of Immune Paralysis. Cancer Res, 2003, 63(21): 7462-7467

[8] OkazakiT., HonjoT.. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol, 2007, 19(7): 813-824

[9] HeL., ZhangG., HeY., et al. . Blockade of B7-H1 with sPD1 improves immunity against murine hepatocarcinoma. Anticancer Res, 2005, 25(5): 3309-3313

[10] DongH., ZhuG., TamadaK., et al. . B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med, 1999, 5(12): 1365-1369

[11] BrownJ.A., DorfmanD.M., MaF.R., et al. . Blockade of programmed death 1 ligands on dendritic cells enhanced T cell activation and cytokine production. J Immunol, 2003, 170(3): 1257-1266

[12] KonishiJ., YamazakiK., AzumaM., et al. . B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res, 2004, 10(15): 5094-5100

[13] GhebehH., MohammedS., Al-OmairA., et al. . The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia, 2006, 8(3): 190-198

[14] StromeS.E., DongH., TamuraH. e. a1.. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res, 2003, 63(19): 6501-6505

[15] ThompsonR.H., KuntzS.M., LeibovichB.C., et al. . Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res, 2006, 66(7): 3381-3385

[16] DasS., SuarezG., BeswickE.J., et al. . Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol, 2006, 176(5): 3000-3009

[17] BlankC., KuballJ., VoelklS., et al. . Blockade of PD-L1(B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer, 2006, 119(2): 317-327

[18] HiranoF., KanekoK., TamuraH., et al. . Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res, 2005, 65(3): 1089-1096

[19] YoshsikoI., MasayoshiI., YoshimasaT. e. a1.. Involvement of PD-LI on tumor cells in the escape from host immune system and tumor immunotherapy by PD-LI blockade. Proc Natl Acad Sci USA, 2003, 99(19): 12293-12297

[20] CurielT.J., WeiS., DongH., et al. . Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med, 2003, 9(5): 562-567